StockWatch
·
Pharmaceuticals
AGM/EGM9 Jul 2026, 07:10 pm

Neuland Laboratories Ltd. to hold 42nd AGM on August 4, 2026

AI Summary

Neuland Laboratories Ltd. has announced its 42nd Annual General Meeting (AGM) will be held on August 4, 2026, at 10:00 a.m. IST, conducted via Video Conferencing (VC)/Other Audio Visual Means (OAVM). The agenda includes the adoption of audited financial statements for the fiscal year ended March 31, 2026, and consolidated financial statements. A final dividend of ₹34 per equity share (340%) for FY2025-26 is recommended. The meeting will also address the re-appointment of a director retiring by rotation, payment of commission to non-executive directors for five years starting FY2026-27, and the appointment of Dr. Mauricio Futran as a Non-Executive Non-Independent Director. Additionally, professional fees for Dr. Futran will be discussed.

Key Highlights

  • AGM scheduled for August 4, 2026, via VC/OAVM.
  • Proposed final dividend of ₹34 per share for FY2025-26.
  • Director re-appointment and appointment of new director on agenda.
  • Discussion on commission payment to non-executive directors.
  • Adoption of FY2026 audited financial statements.